| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Codexis, Inc. (CDXS) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. CDXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 727.1K | $1.72M | - | |
| CEO | 254.3K | $602.8K | - | |
| 10% | 180.0K | $426.6K | - | |
| ? | 139.0K | $329.3K | - | |
| Other | 138.8K | $328.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2019 | Lalonde James | SVP, R&D | Sale+OE | 19,999 | $18.65 | $373,014.54 | -7.0% | |
| Mar 21, 2019 | Sangster Gordon | SVP &Chief Financial Officer | Sale+OE | 80,000 | $20.88 | $1,670,216.00 | -22.9% | |
| Mar 19, 2019 | Nicols John J86 | President And CEO | Sale+OE | 55,072 | $20.83 | $1,147,220.20 | -2.5% | |
| Feb 26, 2019 | Wolf Dennis P77 | Director | Sell | 9,000 | $21.96 | $197,640.00 | -10.4% | |
| Feb 12, 2019 | Lalonde James | SVP, R&D | Sell | 17,915 | $21.63 | $387,561.41 | -6.1% | |
| Jan 25, 2019 | Sangster Gordon | SVP &Chief Financial Officer | Sale+OE | 75,000 | $16.94 | $1,270,178.00 | -21.8% | |
| Dec 28, 2018 | Baruch Thomas R | Director | Sell | 25,000 | $16.03 | $400,801.25 | -10.3% | |
| Dec 26, 2018 | Wolf Dennis P77 | Director | Sell | 9,000 | $15.83 | $142,425.00 | -9.5% | |
| Dec 21, 2018 | Kelley Bernard J | Director | Sell | 10,206 | $16.98 | $173,316.17 | -2.4% | |
| Dec 20, 2018 | Yang Patrick Y72 | Director | Sell | 50,000 | $18.52 | $925,949.92 | -20.5% |